{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:32:14Z","timestamp":1778707934284,"version":"3.51.4"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To evaluate the significance of routinely reported \u2018equivocal\u2019 lymphovascular invasion (\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      ) in prostatectomy specimens of patients with clinically localized prostate cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      Prospectively collected data from men who underwent prostatectomy for clinically localized prostate cancer were retrospectively reviewed. Rates of adverse pathological features and biochemical recurrence (\n                      <jats:styled-content style=\"fixed-case\">BCR<\/jats:styled-content>\n                      ) were compared between tumours positive, negative or \u2018equivocal\u2019 for\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      . Multivariable Cox regression analysis was performed to identify independent predictors of\n                      <jats:styled-content style=\"fixed-case\">BCR<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 1 310 consecutive cases,\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      was present definitively in 82 (6.3%) and equivocally in 43 (3.3%) cases. Similar to definitive\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      , equivocal\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      was significantly associated with other adverse pathological features, including advanced stage, higher Gleason grade and positive surgical margins.\n                      <jats:styled-content style=\"fixed-case\">BCR<\/jats:styled-content>\n                      occurred more frequently in patients with tumours that were equivocal (61%) or positive for\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      (71%) than in patients with negative results (14.7%). In addition, patients with both definitive and equivocal\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      had a significantly shorter\n                      <jats:styled-content style=\"fixed-case\">BCR<\/jats:styled-content>\n                      \u2010free survival time compared with those with negative\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      . Multivariable Cox regression analysis indicated that the presence of either definitive or equivocal\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      were independent predictors of disease recurrence (hazard ratio [\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      ] 3.32, 95% confidence interval [\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      ] 2.3\u20134.8;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001 vs\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      1.66, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.05\u20132.65;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.032, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this single\u2010institution study, equivocal\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      had a similar association with adverse pathological features and rate of\n                      <jats:styled-content style=\"fixed-case\">BCR<\/jats:styled-content>\n                      to that of definitive\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      . If our observations are validated in an independent cohort, consideration should be given to the inclusion of equivocal\n                      <jats:styled-content style=\"fixed-case\">LVI<\/jats:styled-content>\n                      as part of routine pathological reporting.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.13594","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T02:40:51Z","timestamp":1468896051000},"page":"567-572","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Routinely reported \u2018equivocal\u2019 lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes"],"prefix":"10.1111","volume":"119","author":[{"given":"Elena","family":"Galiabovitch","sequence":"first","affiliation":[{"name":"Departments of Urology and Surgery The Royal Melbourne Hospital and University of Melbourne Parkville Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Hovens","sequence":"additional","affiliation":[{"name":"Departments of Urology and Surgery The Royal Melbourne Hospital and University of Melbourne Parkville Vic. Australia"},{"name":"Australian Prostate Cancer Research Centre Epworth Richmond Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin S.","family":"Peters","sequence":"additional","affiliation":[{"name":"Departments of Urology and Surgery The Royal Melbourne Hospital and University of Melbourne Parkville Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Costello","sequence":"additional","affiliation":[{"name":"Departments of Urology and Surgery The Royal Melbourne Hospital and University of Melbourne Parkville Vic. Australia"},{"name":"Australian Prostate Cancer Research Centre Epworth Richmond Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Battye","sequence":"additional","affiliation":[{"name":"TissuPath Specialist Pathology, Mount Waverley and the Faculty of Medicine Monash University Clayton Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Norden","sequence":"additional","affiliation":[{"name":"TissuPath Specialist Pathology, Mount Waverley and the Faculty of Medicine Monash University Clayton Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Ryan","sequence":"additional","affiliation":[{"name":"TissuPath Specialist Pathology, Mount Waverley and the Faculty of Medicine Monash University Clayton Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niall M.","family":"Corcoran","sequence":"additional","affiliation":[{"name":"Departments of Urology and Surgery The Royal Melbourne Hospital and University of Melbourne Parkville Vic. Australia"},{"name":"Australian Prostate Cancer Research Centre Epworth Richmond Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11115.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2014.40"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22903"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.03.020"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.12348"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1303-128"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09848.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2008.02140.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.158"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e3283420155"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102012\u2010002406"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.2361"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12997"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000361"},{"key":"e_1_2_6_16_1","first-page":"541","article-title":"Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy","volume":"45","author":"Hwang JE","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i2.667"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.2340"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26711"},{"key":"e_1_2_6_20_1","first-page":"791","article-title":"Risk factors for recurrence in patients with resected N1 non\u2010small cell lung cancer \u2013 a systematic review and meta\u2010analysis","volume":"20","author":"Luo H","year":"2015","journal-title":"J BUON"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.05.061"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318148c704"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23511"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3881-5"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133355.48672.22"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31806841f6"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.13594","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.13594","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.13594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:06:28Z","timestamp":1761735988000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.13594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/bju.13594"],"URL":"https:\/\/doi.org\/10.1111\/bju.13594","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]},"assertion":[{"value":"2016-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}